Rejuvenation or preservation of germ cells
First Claim
Patent Images
1. A delivery device, comprising:
- a housing including at least one reservoir containing at least one composition including at least one exogenous energy supplying factor including one or more of creatine, phosphocreatine, NADH, FADH2, or ATP;
the reservoir configured to receive and retain the composition, as well as dispense at least a portion of the composition to at least one reproductive cell or tissue and deliver by way of liposomal endocytosis or electroporation;
further including at least one control circuitry configured to control release of the composition or a portion thereof in response to a signal from a sensor.
4 Assignments
0 Petitions
Accused Products
Abstract
Certain embodiments disclosed herein include, but are not limited to, at least one of compositions, methods, devices, systems, kits, or products regarding rejuvenation or preservation of germ cells or gametes. Certain embodiments disclosed herein include, but are not limited to, methods of modifying germ cells or gametes, or methods of administering modified germ cells or gametes to at least one biological tissue.
24 Citations
107 Claims
-
1. A delivery device, comprising:
a housing including at least one reservoir containing at least one composition including at least one exogenous energy supplying factor including one or more of creatine, phosphocreatine, NADH, FADH2, or ATP;
the reservoir configured to receive and retain the composition, as well as dispense at least a portion of the composition to at least one reproductive cell or tissue and deliver by way of liposomal endocytosis or electroporation;
further including at least one control circuitry configured to control release of the composition or a portion thereof in response to a signal from a sensor.- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47)
-
48. A delivery device, comprising:
-
a housing including at least one reservoir containing at least one composition including at least one exogenous energy supplying factor including one or more of creatine, phosphocreatine, NADH, FADH2, or ATP;
the reservoir configured to receive and retain the at least one composition, as well as dispense at least a portion of the composition to at least one reproductive cell or tissue by way of liposomal endocvstosis or electroporation; andfurther including a receiver, wherein the receiver is configured to obtain release instructions or authorization to release the composition. - View Dependent Claims (49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76)
-
-
77. A delivery device, comprising:
-
a housing including at least one reservoir containing at least one composition including at least one exogenous energy supplying factor including one or more of creatine, phosphocreatine, NADH, FADH2, or ATP;
the reservoir configured to receive and retain the at least one composition, as well as dispense at least a portion of the composition to at least one reproductive cell or tissue and deliver the composition by way of liposomal endocytosis or electroporation; andfurther including a detection material, wherein the at least one detection material includes at least one of a diamagnetic particle, ferromagnetic particle, paramagnetic particle, super paramagnetic particle, particle with altered isotope, or other magnetic particle. - View Dependent Claims (78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106)
-
-
107. An implantable delivery device, comprising:
-
an implantable housing including at least one reservoir with at least one micropump, the reservoir containing at least one composition including at least one exogenous energy supplying factor including one or more of creatine, phosphocreatine, NADH, FADH2, or ATP;
the reservoir configured to receive and retain the at least one composition, as well as dispense at least a portion of the composition and deliver it to at least one reproductive cell or tissue by way of liposomal endocytosis or electroporation; andat least one control circuitry configured to control release of the composition or a portion thereof in response to a signal from a sensor.
-
Specification